Chinese Patent Medicine Liu Wei Di Huang Wan Combined with Antihypertensive Drugs, a New Integrative Medicine Therapy, for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled Trials
Table 5
Analyses of diastolic blood pressure.
Trials
WMD (95% CI)
value
LWDHW plus sustained-release nifedipine versus sustained release nifedipine
1
−7.00 (−8.74, −5.26)
<0.00001
LWDHW plus nifedipine controlled release tablet versus nifedipine controlled release tablet
1
−2.25 (−11.90, 7.40)
0.65
LWDHW plus captopril versus captopril
1
−6.75 (−11.26, −2.24)
0.003
LWDHW plus nifedipine controlled release tablet nifedipine controlled release tablet